Results 171 to 180 of about 79,996 (276)

Fully Synthetic, Biomimicking Polysulfates With Tunable Anticoagulant and Endothelial Cell–Selective Bioactivity

Macromolecular Bioscience, Volume 26, Issue 6, June 2026.
Sulfated PHEMA‐based polyelectrolyte brushes are introduced as a reductionist platform to probe glycosaminoglycan‐inspired bioactivity. High charge density governs growth factor interactions and is associated with distinct vascular cell responses, enabling balanced endothelial and smooth muscle cell co‐culture.
Andrea Cosimi, Roxana Pollehn, Andrea De Martino, Scarlett Manzke, Yannic Kerkhoff, Philip Nickl, Theresa Lohmann, Eriselda Keshi, Cornelia Lee‐Thedieck, Marie Weinhart   +9 more
wiley   +1 more source

Identifying the silent deficiency: Severe Factor XI deficiency in an asymptomatic patient with isolated prolonged activated partial thromboplastin time-A case report. [PDF]

SAGE Open Med Case Rep
Alshurafa A, Draidi M, Ibrahim F, Mohamed SF, Yassin MA.   +4 more
europepmc   +1 more source

International normalized ratio and activated partial thromboplastin time testing. [PDF]

CMAJ, 2022
Chornenki NLJ, Fralick M, Sholzberg M.
europepmc   +1 more source

Humoral antibodies and coagulation mechanisms in the accelerated or hyperacute rejection of renal homografts in sensitized canine recipients. [PDF]

, 1970
Amemiya, H, Boehmig, HJ, Bunch, DL, Coburg, AJ, Dixon, FJ, Giles, GR, Hathaway, WE, Simpson, KM, Starzl, TE, Wilson, CB   +9 more
core  

Short‐Term, Cycle‐Synchronized Adjunctive Therapy With Crocus Total Glucosides Tablets for Cardiac Protection Against Cancer Therapy‐Related Cardiac Dysfunction in Breast Cancer Patients: A Randomized, Double‐Blind, Placebo‐Controlled Trial

MedComm, Volume 7, Issue 6, June 2026.
Cycle‐synchronized CTGT therapy attenuates LVGLS decline and reduces CTRCD in breast cancer patients. This randomized, double‐blind, placebo‐controlled trial assessed whether cycle‐synchronized CTGT prevent CTRCD in 120 breast cancer patients receiving chemotherapy.
Xiaoling Liu, Mengmeng Li, Wenwen Song, Yu Zhang, Wuyun Bao, Chaoyu Liu, Yuan Zhang, Quande Liu, Cheng Zhang, Yun Zhang, Li Li, Mei Zhang   +11 more
wiley   +1 more source

Diagnostic Performance of Prothrombin Time and Activated Partial Thromboplastin Time in Children: A Service Evaluation. [PDF]

Int J Lab Hematol
Gurumurthy G, Lemma M, Reynolds L, Grainger J, Thachil J.   +4 more
europepmc   +1 more source

Comparative analysis on characteristics of two activated partial thromboplastin time reagents. [PDF]

J Clin Lab Anal, 2022
Yasui Y, Ishii T, Tatebe J, Morita T.
europepmc   +1 more source

Clinical heterotransplantation of the liver. [PDF]

, 1970
Amemiya, H, Boehmig, HJ, Giles, GR, Halgrimson, CG, Starzl, TE   +4 more
core  

Age‐Dependent Differences in Canakinumab Safety: A Comprehensive Pharmacovigilance Analysis Using the FAERS Database

Pharmacology Research &Perspectives, Volume 14, Issue 3, June 2026.
ABSTRACT While the efficacy of canakinumab, an anti‐interleukin‐1β monoclonal antibody, is well‐established, its safety profile, particularly across different age groups, remains inadequately explored. Using the FDA Adverse Event Reporting System (FAERS) database, this study evaluated postmarketing safety by analyzing adverse event (AE) reports from ...
Youyang Wang, Ngasin Lam, Xiaoming Huang, Yang Jiao   +3 more
wiley   +1 more source

Laboratory Identification of Lupus Anticoagulant (LA) Using Different Activated Partial Thromboplastin Time (APTT) Assays. [PDF]

Int J Lab Hematol
Barion BG, Stefanello B, de Paula MLSA, Saraiva TS, Villaça PR, Rocha V, Orsi FA, da Rocha TRF.   +7 more
europepmc   +1 more source